1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Metabolic Enzyme/Protease
    Vitamin D Related/Nuclear Receptor
  3. PPAR

PPAR

PPAR

Peroxisome proliferator-activated receptors

PPARs (Peroxisome proliferator-activated receptors) are ligand-activated transcription factors of nuclear hormone receptor superfamily comprising of the following three subtypes: PPARα, PPARγ, and PPARβ/δ. PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lipid, protein), and tumorigenesis of higher organisms. All PPARs heterodimerize with the retinoid X receptor (RXR) and bind to specific regions on the DNA of target genes. Activation of PPAR-α reduces triglyceride level and is involved in regulation of energy homeostasis. Activation of PPAR-γ enhances glucose metabolism, whereas activation of PPAR-β/δ enhances fatty acids metabolism.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0163R
    Magnolol (Standard)
    Agonist
    Magnolol (Standard) is the analytical standard of Magnolol. This product is intended for research and analytical applications. Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively.
    Magnolol (Standard)
  • HY-B0700
    Rosiglitazone sodium
    Activator
    Rosiglitazone sodium is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone sodium is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).
    Rosiglitazone sodium
  • HY-114822
    Prostaglandin A3
    Prostaglandin A3 is a non-enzymatic dehydration product of prostaglandin E3 (PGE3). Prostaglandin A3 showed good affinity for canine EP2 and EP4 receptors with IC50 values of 120 and 20 nM, respectively. The Ki value of Prostaglandin A3 for human PPARγ was 188 μM.
    Prostaglandin A3
  • HY-116259
    PT-S58
    Antagonist
    PT-S58, a GSK0660 derivative, is a PPARβ/δ full antagonist with an IC50 value of 98 nM. PT-S58 inhibits the agonist-induced transcriptional activity of PPARβ/δ in vitro.
    PT-S58
  • HY-155704
    Lyciumamide A
    Antagonist
    DPP-IV-IN-5 is isolated from the fruits of Lycium barbarum. DPP-IV-IN-5 exerts moderate agonistic activities for peroxisome proliferator-activated receptor (PPARγ) with EC50 values of 10.09 - 44.26 μM and also presents inhibitory activity on dipeptidyl peptidase-4 (DPPIV) with an IC50 value of 47.13 μM .
    Lyciumamide A
  • HY-Y0078S
    Cinnamyl Alcohol-d5
    Inhibitor
    Cinnamyl Alcohol-d5 is deuterated labeled 3-Methyl-2-cyclopenten-1-one (HY-W013014). 3-Methyl-2-cyclopenten-1-one is an endogenous metabolite.
    Cinnamyl Alcohol-d<sub>5</sub>
  • HY-125716
    DRF-2519 free base
    Activator
    DRF-2519 (free base) is a dual activator of PPAR α and PPAR γ. DRF-2519 (free base) has antidiabetic and hypolipidemic activity.
    DRF-2519 free base
  • HY-N11924
    Foenumoside B
    Inhibitor
    Foenumoside B is a triterpene saponin isolated from Lysimachia foenum-graecum. Foenumoside B activates AMPK signaling, inhibits PPARγ-induced adipogenesis, and shifts lipid metabolism toward lipolysis. Foenumoside B can be used in the study of obesity and obesity-related metabolic diseases.
    Foenumoside B
  • HY-117431
    Prostaglandin B3
    Agonist
    Prostaglandin B3 (PGB3) is a member of the class of prostaglandins B and a secondary alcohol. PGB3 exhibits a rather low affinity to human PPARγ with a Ki value greater than 1 mM compared with Ki values of 26.28 ± 8.7 μM for PGB1 and 77 ± 37.7 μM for PGB2.
    Prostaglandin B3
  • HY-100277R
    Mifobate (Standard)
    Inhibitor
    Mifobate (Standard) is the analytical standard of Mifobate. This product is intended for research and analytical applications. Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects.
    Mifobate (Standard)
  • HY-114853
    BVT.13
    Agonist
    BVT.13 is an orally active and selective PPARγ agonist with a maximal efficacy similar to that of Rosiglitazone (HY-17386). In addition, BVT.13 exhibits antidiabetic activity in ob/ob mice.
    BVT.13
  • HY-14739R
    Choline Fenofibrate (Standard)
    Agonist
    Choline Fenofibrate (Standard) is the analytical standard of Choline Fenofibrate. This product is intended for research and analytical applications. Choline Fenofibrate (ABT-335), a choline salt of Fenofibric acid (HY-B0760), releases free Fenofibric acid in the gastrointestinal tract. Fenofibric acid is a PPAR activator with antihyperlipidemic effect.
    Choline Fenofibrate (Standard)
  • HY-156977
    Sitofibrate
    Agonist
    Sitofibrate is a Clofibrate (HY-B0287) derivative. Sitofibrate is aperoxisome proliferator activated receptor-α (PPAR-α) agonist. Sitofibrate is an antihyperlipidemic agent.
    Sitofibrate
  • HY-119311
    Ketopioglitazone
    Agonist
    Pioglitazone ketone is an active metabolite of the PPARγ agonist Pioglitazone (HY-13956). Formation of pioglitazone ketone occurs primarly through cytochrome P450 (CYP) isoform CYP2C8-mediated metabolism of pioglitazone. Pioglitazone ketone (100 mg/kg in the diet) reduces blood glucose levels in a KKAy mouse model of type 2 diabetes.
    Ketopioglitazone
  • HY-113820
    AZD4619
    Agonist
    AZD4619 is an orally active, selective peroxisome proliferator-activated receptor α (PPARα) agonist. AZD4619 increases alanine aminotransferase 1 (ALT1) protein expression in a dose-dependent manner in human, but not in rat primary hepatocytes. AZD4619 is a lipid-lowering drug.
    AZD4619
  • HY-160003
    PPARγ agonist 9
    Agonist
    PPARγ agonist 9 is an agonist of PPARγ. PPARγ agonist 9 is the analogue of lysophosphatidic acid with an EC50 more than 10 μM for LPA3 receptor.
    PPARγ agonist 9
  • HY-17386S1
    Rosiglitazone-d4
    Agonist
    Rosiglitazone-d4 is deuterated labeled Rosiglitazone (HY-17386). Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer.
    Rosiglitazone-d<sub>4</sub>
  • HY-B0258S1
    Gemfibrozil-d6-1
    Activator
    Gemfibrozil-d6-1 (CI-719-d6-1) is the deuterium labeled Gemfibrozil (HY-B0258). Gemfibrozil is an activator of PPAR-α, used as a lipid-lowering agent; Gemfibrozil is also a nonselective inhibitor of several P450 isoforms, with Ki values for CYP2C9, 2C19, 2C8, and 1A2 of 5.8, 24, 69, and 82 μM, respectively.
    Gemfibrozil-d<sub>6</sub>-1
  • HY-120255A
    17(S)-HDHA
    Activator
    17(S)-HDHA is a pro-resolving mediator (SPM). 17(S)-HDHA slightly activats PPARγ, PPARα and PPARδ.
    17(S)-HDHA
  • HY-N2118R
    Bilobetin (Standard)
    Activator
    Bilobetin (Standard) is the analytical standard of Bilobetin. This product is intended for research and analytical applications. Bilobetin, an active component of Ginkgo biloba, can reduce blood lipids and improve the effects of insulin. Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. Bilobetin also increased the phosphorylation, nuclear translocation and activity of PPARα accompanied by elevated cAMP level and PKA activity.
    Bilobetin (Standard)
Cat. No. Product Name / Synonyms Species Source
Cat. No. Product Name / Synonyms Application Reactivity

PPARα

PPARβ/δ

PPARγ

PPAR

PPARδ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PPAR Inducers, Ligands, Inhibitors, Agonists, Antagonists, Activators & Modulators
Product NamePPARαPPARβ/δPPARγPPARPPARδPurity    
Retinoic acid
PPARα, Kd: 103 nM
PPARα, IC50: 14 nM
PPARβ/δ, Kd: 17 nM
RARβ, IC50: 14 nM
PPARγ, Kd: 178 nM
PPARγ, IC50: 14 nM
  99.81%
Rosiglitazone  
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
  99.94%
GW9662
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
PPARγ, IC50: 3.3 nM
  99.79%
Pioglitazone
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
  99.89%
Fenofibrate
PPARα, IC50: 30 μM
    99.97%
1,1'-(Azodicarbonyl)-dipiperidine
PPARα
 
PPAR-γ
 
PPARδ
GW6471
PPARα
    99.64%
5-Aminosalicylic Acid  
PPARγ
  99.82%
Pirinixic acid
PPARα, EC50: 0.63 μM
 
PPARγ, EC50: 32 μM
  98.81%
Troglitazone  
PPARγ, EC50: 550 nM (Human PPARγ)
  99.78%
T0070907
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
PPARγ, Ki: 1 nM
  99.98%
Astaxanthin  
PPARγ
  ≥98.0%
Daidzein
PPAR-α
 
PPAR-γ
  99.72%
Icariin
PPARα
    99.06%
GW7647
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
PPARγ, EC50: 1.1 μM (Human PPARγ)
  99.45%
GW 501516 
PPARδ, EC50: 1.1 nM
   99.27%
GW1929  
PPAR-γ, pEC50: 8.56 (Human PPAR-γ)
  99.93%
Elafibranor
PPAR-α, EC50: 45 nM
PPAR-δ, EC50: 175 nM
   99.66%
Oleuropein  
PPARγ
  99.05%
Anandamide   
PPAR
 ≥99.0%
Pioglitazone hydrochloride
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
PPARγ, EC50: 43 μM (Human PPARγ)
  99.97%
Bezafibrate
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
hPPARγ, EC50: 60 μM
  99.83%
Magnolol  
PPARγ, EC50: 17.7 μM
  99.84%
Glabridin  
PPARγ, EC50: 6.1 μM
  99.98%
Fucoxanthin
PPARα
 
PPARγ
  98.99%
GW0742
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
PPARγ, EC50: 2 μM
  99.94%
Palacaparib   
PPAR
 99.11%
Oleoylethanolamide
PPAR-α
    98.19%
GSK3787 
PPARδ, pIC50: 6.6 nM
   98.11%
Dehydroepiandrosterone sulfate
PPARα
    99.93%
1-Methyladenosine  
PPAR-γ
  99.21%
GSK0660 
PPARβ/δ, IC50: 155 nM
   99.49%
Gemfibrozil
PPAR-α
    99.91%
Rosiglitazone maleate  
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
  99.73%
FH535   
PPAR
 99.88%
Palmitelaidic Acid
PPARα
    ≥99.0%
Pemafibrate
h-PPARα, EC50: 1 nM
PPARδ, EC50: 1.58 μM
h-PPARγ, EC50: 1.1 μM
  99.85%
CDDO-Im
PPARα, Ki: 232 nM
 
PPARγ, Ki: 344 nM
  99.30%
Candesartan  
PPAR-γ
  98.03%
Retinoic acid (Standard)
PPARα
PPARβ/δ
RARβ
PPARγ
  
Dehydroepiandrosterone sulfate sodium
PPARα
    99.96%
1,2-DLPC
PPARα
    ≥98.0%
Chiglitazar
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
PPARγ, EC50: 0.08 μM
  99.81%
Seladelpar
PPAR-α, EC50: 1600 nM
PPAR-δ, EC50: 2 nM
   99.75%
Bavachinin
PPARα, IC50: 21.043 μM
PPARδ, IC50: 12.819 μM
PPAR-γ, IC50: 0.622 μM
  99.95%
FX-909  
PPARγ
  99.79%
15-Deoxy-Δ-12,14-prostaglandin J2  
PPARγ, EC50: 2 μM
  ≥99.0%
Eupatilin
PPARα
    98.90%
Fenofibric acid
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
PPARγ, EC50: 1.47 μM
  99.94%
Fmoc-leucine  
PPARγ
  99.91%
Alpinetin  
PPAR-γ
  99.51%
Rosiglitazone hydrochloride  
PPARγ, EC50: 60 nM
PPARγ, Kd: 40 nM
  99.81%
Saroglitazar
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
  99.10%
Clofibrate
PPARα, EC50: 50 μM
 
PPARγ, EC50: 500 μM
  99.61%
Seladelpar sodium salt 
PPAR-δ, EC50: 2 nM
   98.77%
Ginsenoside Rh1  
PPAR-γ
  ≥98.0%
Agrimol B  
PPARγ
  99.75%
Bilobetin
PPARα
    99.39%
SR1664  
PPAR-γ, IC50: 80 nM
  ≥98.0%
DG172 dihydrochloride 
PPARβ/δ, IC50: 27 nM
   99.35%
Ophiopogonin D
PPARα
    99.54%
NXT629
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
hPPARγ, IC50: 15 μM
  99.07%
Avicularin  
PPARγ
  99.80%
Cefminox sodium  
PPARγ
  99.83%
Norathyriol
PPARα, IC50: 92.8 μM
PPARβ, IC50: 102.4 μM
PPARγ, IC50: 153.5 μM
  99.83%
Oroxin A  
PPARγ
  99.76%
Hexadecanamide
PPARα
    
4-O-Methyl honokiol  
PPARγ
  98.18%
MTX-531  
PPARγ, EC50: 3.4 μM
  99.87%
Ertiprotafib
PPARα, EC50: ~1 μM
PPARβ, EC50: ~1 μM
   98.86%
Mifobate  
PPARγ, IC50: 140 μM
  99.10%
PPARα/γ agonist 1
PPARα, EC50: 28 nM
 
PPARγ, EC50: 69 nM
  99.68%
Glabrone  
PPAR-γ
  99.08%
Gypenoside XLIX
PPAR-α
    99.99%
BAY-4931  
PPAR-γ, IC50: 0.17 nM (RT112-FABP4-NLucP cellular reporter assay)
mouse PPARγ, IC50: 0.14 nM (GAL4-NHR-LBD one hybrid reporter assay )
hPPARγ, IC50: 0.40 nM (GAL4-NHR-LBD one hybrid reporter assay )
  98.83%
Ciprofibrate
PPARα
    99.93%
AMG131  
PPARγ
  99.64%
Licarin B  
PPARγ
  99.93%
L-165041 
PPARδ, Ki: 6 nM
PPARγ, Ki: 730 nM
  99.67%
Leriglitazone hydrochloride  
PPAR-γ, EC50: 9 μM
  99.64%
D-arabinose  
PPAR-γ
  ≥99.0%
Raspberry ketone
PPAR-α
    99.91%
PPARγ-IN-2  
PPARγ
  99.57%
Saroglitazar magnesium
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
  98.85%
Darglitazone  
PPAR-γ
  99.19%
Psammaplin A  
PPARγ
  
GSK1820795A  
hPPARγ, EC50: 0.25 μM
mouse PPARγ, EC50: 0.27 μM
  99.76%
BMS-687453
PPARα, IC50: 260 nM (Human PPARα)
    99.31%
(10E,12Z)-Octadeca-10,12-dienoic acid
PPARα
    99.10%
Etrinabdione  
PPARγ
  99.16%
Clitorin
PPARα
    99.45%
Leriglitazone  
PPAR-γ, EC50: 9 μM
  99.23%
Indeglitazar
PPARα
PPARδ
PPARγ
  99.11%
Drupanin
PPARα, EC50: 39.0 μM
 
PPARγ, EC50: 14.6 μM
  98.05%
Lobeglitazone
PPARα, EC50: 546.3 nM
 
PPARγ, EC50: 137.4 nM
  
Daidzein (Standard)
PPAR-α
 
PPAR-γ
  99.46%
HWL-088 
PPARδ, EC50: 570.9 nM
   98.61%
Adelmidrol  
PPARγ
  ≥98.0%
BAY-0069  
hPPARγ, IC50: 6.3 nM
mouse PPARγ, IC50: 24 nM
  98.07%
LT175
hPPARα, EC50: 0.22 μM
mPPARα, EC50: 0.26 μM
 
hPPARγ, EC50: 0.48 μM
  99.79%
SR 16832  
PPARγ
  99.89%
GW 9578
mouse PPARα, EC50: 5 nM
h-PPARα, EC50: 50 nM
    99.6%
Aleglitazar
PPARα, IC50: 38 nM
 
PPARγ, IC50: 19 nM
  99.74%
Balaglitazone  
PPARγ, EC50: 351 nM (Human PPARγ)
  99.74%
Azemiglitazone potassium  
PPAR-γ, IC50: 18.25 μM
  99.53%
Inolitazone dihydrochloride  
PPARγ
  98.86%
CP-868388 free base
hPPARα, Ki: 10.8 nM
 
hPPARγ, Ki: 3.47 μM
  99.66%
F44-A13
PPARα
PPARβ
   
Methyl oleanonate  
PPARγ
  99.81%
CUDA
PPARα
    ≥98.0%
FTX-6746  
PPARγ
  98.68%
Edaglitazone
PPARα, EC50: 1053 nM
 
PPARγ, EC50: 35.6 nM
  99.58%
ST247 
PPARβ/δ
   99.88%
Fenofibrate (Standard)
PPARα
    99.91%
FK614  
PPAR-γ
  99.97%
Falcarindiol  
PPARγ
  99.48%
25-Hydroxytachysterol3  
PPARγ
  98.89%
Lobeglitazone sulfate
PPARα, EC50: 546.3 nM
 
PPARγ, EC50: 137.4 nM
  99.63%
Dehydroepiandrosterone sulfate-d6 sodium dihydrate
PPARα
    98.00%
Fenofibric acid (Standard)
PPARα
PPARδ
PPARγ
  99.16%
Dehydroepiandrosterone sulfate (Standard)
PPARα
    
1-O-Hexadecylglycerol  
PPAR-γ
  ≥98.0%
SR 11023  
PPARγ, IC50: 108 nM
  99.55%
Netoglitazone
PPARα
 
PPARγ
  99.88%
H-​Trp-​Glu-​OH  
PPARγ, Kd: 8 μM
  99.95%
PPARγ phosphorylation inhibitor 1  
PPARγ, IC50: 24 nM
  99.81%
Dehydroepiandrosterone sulfate sodium-d6
PPARα
    99.61%
(±)4-HDHA  
PPARγ
  99.05%
BAY-5094  
PPAR-γ
  98.04%
MA-0204 
PPARδ, EC50: 0.4 nM (in human)
PPARδ, EC50: 7.9 nM (in mouse)
PPARδ, EC50: 10 nM (in rat)
   99.31%
MRL-24  
PPARγ
  
10-Nitrolinoleic acid  
PPARγ, IC50: 0.22 μM
  
Clofibrate (Standard)
PPARα
 
PPARγ
  98.09%
SDPC  
PPARγ
  
Angeloylgomisin H  
PPAR-γ
  99.79%
Gemfibrozil (Standard)
PPAR-α
    99.90%
PPARγ agonist 14  
PPARγ, EC50: 2.4 μM
  
13-Oxo-9E,11E-octadecadienoic acid
PPARα
    
GSK376501A  
PPARγ
  99.06%
PPAR agonist 5
PPARα, EC50: 3.20 μM
PPARβ/δ, EC50: 1.51 μM
PPARγ, EC50: 1.92 μM
  
SKLB102  
PPAR-γ
  
Arhalofenate  
PPAR-γ
  
PPAR agonist 1
PPARα
 
PPARγ
  98.39%
Rosiglitazone potassium  
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
  
Pparδ agonist 5    
PPARδ, EC50: 0.335 μM
Seladelpar Lysine dihydrate    
PPARδ, EC50: 2 nM
≥98.0%
Pioglitazone potassium
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
mouse PPARγ, EC50: 0.99 μM
h-PPARγ, EC50: 0.93 μM
  
9(10)-Nitrooleate
PPARα
PPARβ/δ
PPARγ
  
PPARα/δ agonist 2
PPARα, EC50: 3255 nM
PPARβ/δ, EC50: 1475 nM
   
Ciprofibrate impurity A
PPARα
    
BMS711939
hPPARα, IC50: 4 nM
 
hPPARγ, IC50: 4.5 μM
  
MBX-102 acid  
PPARγ
  
Tibesaikosaponin V  
PPARγ
  
PPARγ-IN-3  
PPARγ
  
PPAR agonist 4
PPARα, EC50: 0.7 μM
 
PPARγ, EC50: 1.8 μM
 
PPARδ, EC50: 0.7 μM
LJ570
PPARα, EC50: 1.05 μM
 
PPARγ, EC50: 0.12 μM
  
PPARγ/δ modulator 2  
PPARγ
 
PPARδ
Caulophyllogenin  
PPARγ, EC50: 12.6 μM
  
Pparδ agonist 1 
PPARδ, EC50: 5.06 nM
   
Darglitazone Sodium  
PPAR-γ
  
Rac-Pemafibrate
h-PPARα, EC50: 1 nM
h-PPARδ, EC50: 1.7 μM
   
PPARγ/δ modulator 1  
PPARγ, Ki: 5.31 μM
 
PPARδ, Ki: 14.4 nM
Imiglitazar
PPARα, EC50: 67 nM
 
PPARγ1, EC50: 31 nM
  
GW1929 hydrochloride  
hPPARγ, pKi: 8.84
  
Fonadelpar 
PPARδ
   
Icariin (Standard)
PPARα
    
Cinoxate  
PPARγ, Ki: 18 μM
  
Cevoglitazar
PPARα
 
PPARγ
  
Pparδ agonist 2 
PPARδ
   
PPARγ agonist 16  
PPAR-γ, IC50: 1790 nM
  
Apo-12'-lycopenal  
PPAR-γ
  
KD-3010 
PPARδ
   
PPARγ agonist 8  
PPARγ
  
Eupatilin (Standard)
PPARα
    
DS-6930  
PPARγ, EC50: 41 nM
  
Romazarit
PPARα
    
Ginsenoside Rh1 (Standard)  
PPAR-γ
  
PPARα agonist 5
PPARα, EC50: 3 nM
 
PPAR-γ, EC50: 1.66 μM
 
PPARδ, EC50: >25 μM
PPARα/δ agonist 1
PPARα, EC50: 7 nM
 
PPARγ, EC50: 1316.1 nM
 
PPARδ, EC50: 8.4 nM
99.59%
SR2595  
PPARγ, IC50: 30 nM
  
PPARδ agonist 10    
PPARδ, EC50: 0.053 μM (hPPARδ)
PPARδ, EC50: 0.30 μM (mPPARδ)
PPARγ modulator-1  
PPAR-γ
  
L-783483    
PPARδ
PPARδ agonist 11
hPPARα, EC50: 8 μM
hPPARδ, EC50: 0.02 μM
   
PPARγ agonist 2  
PPARγ
  
PPARα/δ agonist 3
PPARα, IC50: 5.6 nM
 
PPARγ, IC50: 1278 nM
 
PPARδ, IC50: 3.4 nM
CAY10410  
PPARγ
  
Mesalamine impurity P   
PPAR
 
15-LOX-IN-2  
PPARγ
  
Dehydroepiandrosterone sulfate sodium (Standard)
PPARα
    
GW7845  
PPARγ
  
ZLY06  
PPARγ, IC50: 237 nM
 
PPARδ, IC50: 341 nM
PPARα agonist 1
hPPARα
    
4,5-DiHDPA lactone  
PPARγ
  
PPARγ modulator-3  
PPARγ, Kd: 186 nM
  
Amezalpat
PPARα, IC50: 58 nM
    
E0924G 
PPARδ, EC50: 2.82 μM
   99.17%
PPARγ-IN-5  
PPARγ
  
Glabridin (Standard)  
PPARγ
  
YGT-31  
PPARγ, IC50: 1.72 μM
PPARγ, Ki: 0.62 μM
  
PPARγ/GR modulator 1  
PPARγ, Ki: 3.3 μM
  
Avicularin (Standard)  
PPARγ
  
PPARα/γ agonist 2
PPARα, EC50: 0.95 μM
 
PPARγ, EC50: 0.91 μM
  
PPARα/γ agonist 4
PPARα
 
PPAR-γ
  
PPARγ modulator-2  
PPARγ, IC50: 41 nM
  
DSO-5a  
PPARγ
  
Chiglitazar sodium
PPARα, EC50: 1.8 μM
PPAR-δ, EC50: 1.7 μM
PPAR-γ, EC50: 0.08 μM
  
Elaidyl-sulfamide
PPARα
    
Rosiglitazone sodium  
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
  
Prostaglandin A3  
PPAR-γ, Ki: 188 μM
  
PT-S58 
PPARβ/δ, IC50: 98 nM
   
Prostaglandin B3  
PPARγ
  
Sitofibrate
PPAR-α
    
AZD4619
PPARα
    
T2384  
PPARγ
  
SR-1903  
PPARγ, IC50: 209 nM
  
Inolitazone  
PPARγ
  
17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid  
PPARγ
  
GW 2433
PPARα
   
PPARδ
ZINC17167211
PPAR-α, EC50: 0.16 nM
    
TZD18
hPPARα, IC50: 0.028 μM
 
hPPARγ, IC50: 0.057 μM
 
PPARδ, IC50: >10 μM
AVE-8134
PPARα, EC50: 100 nM (Human PPARα)
    
GW409544
PPARα, EC50: 2.3 nM
 
PPAR-γ, EC50: 0.28 nM
  
CLX-0921  
PPARγ, IC50: 1.54 μM
  
N-Octadecyl-N'-propyl-sulfamide
PPARα
    
NS-220
PPARα, EC50: 19 nM
 
PPARγ, EC50: 9.6 μM
 
PPARδ, EC50: >1 mM
PPARα agonist 2
PPARα, EC50: 37 nM
    
PPARα-MO-1
PPARα